Author correction: elexacaftor is a cftr potentiator and acts synergistically with ivacaftor during acute and chronic treatment

Correction to: _Scientific Reports_ https://doi.org/10.1038/s41598-021-99184-1, published online 06 October 2021 The original version of this Article contained an error in Figure 3 and 4

where the graph for panel C was omitted. The original Figures 3 and 4 and accompanying legends appear below. The original Article has been corrected. AUTHOR INFORMATION AUTHORS AND

AFFILIATIONS * Department of Pediatrics, National Jewish Health, Denver, CO, USA Ciaran A. Shaughnessy, Pamela L. Zeitlin & Preston E. Bratcher * Department of Pediatrics, University of

Colorado Anschutz Medical Center, Aurora, CO, USA Pamela L. Zeitlin & Preston E. Bratcher Authors * Ciaran A. Shaughnessy View author publications You can also search for this author

inPubMed Google Scholar * Pamela L. Zeitlin View author publications You can also search for this author inPubMed Google Scholar * Preston E. Bratcher View author publications You can also

search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Ciaran A. Shaughnessy. RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative

Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the

original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in

the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your

intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence,

visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Shaughnessy, C.A., Zeitlin, P.L. & Bratcher, P.E. Author Correction:

Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment. _Sci Rep_ 11, 21295 (2021). https://doi.org/10.1038/s41598-021-00539-5 Download

citation * Published: 25 October 2021 * DOI: https://doi.org/10.1038/s41598-021-00539-5 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get

shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative